These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 8447720)

  • 1. Comparing Pneumocystis carinii pneumonia prophylactic regimens.
    Khaliq Y; Lamp KC
    Arch Intern Med; 1993 Mar; 153(6):782-3. PubMed ID: 8447720
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
    Warnock AC; Rimland D
    Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A meta-analysis of the relative efficacy and toxicity of Pneumocystis carinii prophylactic regimens.
    Ioannidis JP; Cappelleri JC; Skolnik PR; Lau J; Sacks HS
    Arch Intern Med; 1996 Jan; 156(2):177-88. PubMed ID: 8546551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment and prophylaxis of Pneumocystis carinii pneumonia.
    Castro M
    Semin Respir Infect; 1998 Dec; 13(4):296-303. PubMed ID: 9872626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High failure rate of dapsone and pentamidine as Pneumocystis carinii pneumonia prophylaxis in human immunodeficiency virus-infected children.
    Nachman SA; Mueller BU; Mirochnick M; Pizzo PA
    Pediatr Infect Dis J; 1994 Nov; 13(11):1004-6. PubMed ID: 7845719
    [No Abstract]   [Full Text] [Related]  

  • 6. Recent advances in the prevention of pneumocystis carinii pneumonia.
    Hughes WT
    Adv Pediatr Infect Dis; 1996; 11():163-86. PubMed ID: 8718463
    [No Abstract]   [Full Text] [Related]  

  • 7. Pneumocystis carinii dihydropteroate synthase but not dihydrofolate reductase gene mutations correlate with prior trimethoprim-sulfamethoxazole or dapsone use.
    Ma L; Borio L; Masur H; Kovacs JA
    J Infect Dis; 1999 Dec; 180(6):1969-78. PubMed ID: 10558954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of dihydropteroate synthase gene typing for Pneumocystis carinii f.sp. hominis epidemiology.
    Santos LD; Lacube P; Latouche S; Kac G; Mayaud C; Marteau M; Poirot JL; Maury E; Guillot J; Roux P
    J Eukaryot Microbiol; 1999; 46(5):133S-134S. PubMed ID: 10519287
    [No Abstract]   [Full Text] [Related]  

  • 9. [Therapy and prevention of pneumocystis carinii pneumonia].
    Goebel FD; Bogner JR
    Internist (Berl); 1995 Dec; 36(12):1150-5. PubMed ID: 8567220
    [No Abstract]   [Full Text] [Related]  

  • 10. Randomized trial of weekly sulfadoxine/pyrimethamine vs. daily low-dose trimethoprim-sulfamethoxazole for the prophylaxis of Pneumocystis carinii pneumonia after liver transplantation.
    Torre-Cisneros J; De la Mata M; Pozo JC; Serrano P; Briceño J; Solórzano G; Miño G; Pera C; Sánchez-Guijo P
    Clin Infect Dis; 1999 Oct; 29(4):771-4. PubMed ID: 10589886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumocystis carinii pneumonia treatment in people infected with HIV.
    Bellamy R
    Clin Evid; 2004 Jun; (11):935-50. PubMed ID: 15652046
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of pneumonia related to HIV--pneumocystis carinii pneumonia (PCP)].
    Sidahora; 1995; ():31-2. PubMed ID: 11363204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adherence to PCP medications found to be low.
    TreatmentUpdate; 1998 Sep; 10(7):2-3. PubMed ID: 11365780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Editorial response: Prophylaxis for Pneumocystis carinii pneumonia--an evolving tale of two populations.
    Gaut P; Daar ES
    Clin Infect Dis; 1999 Oct; 29(4):784-6. PubMed ID: 10589888
    [No Abstract]   [Full Text] [Related]  

  • 15. Successful intermittent prophylaxis with trimethoprim/sulfamethoxazole 2 days per week for Pneumocystis carinii (jiroveci) pneumonia in pediatric oncology patients.
    Lindemulder S; Albano E
    Pediatrics; 2007 Jul; 120(1):e47-51. PubMed ID: 17606548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
    González-García J; Rubio García R; Antela López A; García Alcaide F
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomized trial comparing the toxicity and safety of atovaquone with trimethoprim/sulfamethoxazole as Pneumocystis carinii pneumonia prophylaxis following autologous peripheral blood stem cell transplantation.
    Colby C; McAfee S; Sackstein R; Finkelstein D; Fishman J; Spitzer T
    Bone Marrow Transplant; 1999 Oct; 24(8):897-902. PubMed ID: 10516703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ineffectiveness of trimethoprim-sulfamethoxazole prophylaxis and the importance of bacterial and viral coinfections in African children with Pneumocystis carinii pneumonia.
    Madhi SA; Cutland C; Ismail K; O'Reilly C; Mancha A; Klugman KP
    Clin Infect Dis; 2002 Nov; 35(9):1120-6. PubMed ID: 12384847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Pneumocystis carinii pneumonia in adults with AIDS.
    Deresinski SC
    Semin Respir Infect; 1997 Jun; 12(2):79-97. PubMed ID: 9195673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. P. carinii pneumonia in African children and the ineffectiveness of TMP-SMX prophylaxis.
    Cruciani M; Malena M; Mengoli C
    Clin Infect Dis; 2003 Apr; 36(7):937-9; author reply 939-40. PubMed ID: 12652402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.